Diane Doughty

Diane Doughty is a seasoned professional in device development, currently serving as the Director of Device Development at REGENXBIO Inc. since April 2020, where responsibilities include leading the development of medical devices for ocular and CNS delivery of AAV gene therapy. Prior experience includes various roles at AstraZeneca from January 2010 to April 2020, including Associate Director and Principal Engineer, focusing on drug delivery technologies for late-stage biologics. Earlier positions include Scientist roles and project involvement in drug delivery technologies at the University of Maryland School of Pharmacy, where Diane conducted usability testing, and internships at Schering-Plough and Teva Pharmaceuticals. Diane holds a Bachelor of Science in Biology with a concentration in genetics from Penn State University and a Ph.D. in Pharmaceutical Sciences from the University of Maryland School of Pharmacy.